{
    "Trade/Device Name(s)": [
        "U-RIGHT TD-4238 Blood Glucose Monitoring System",
        "U-RIGHT TD-4246 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K092902",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090187"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "February 4, 2010",
    "Summary Letter Received Date": "February 4, 2010",
    "Submission Date": "09/17/2009",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "U-RIGHT TD-4238 Blood Glucose Meter",
        "U-RIGHT TD-4246 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose oxidase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control solution",
        "Lancet",
        "Lancing device",
        "User Manual",
        "Storage Pack"
    ],
    "Document Summary": "FDA 510(k) summary for U-RIGHT TD-4238 and TD-4246 Blood Glucose Monitoring Systems for quantitative measurement of blood glucose using an electrochemical biosensor",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from finger and alternative sites to aid in monitoring diabetes control; not for diagnosis, screening, or use on neonates",
    "fda_folder": "Clinical Chemistry"
}